Jianlong Lou

Author PubWeight™ 28.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol 2006 2.66
2 Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Cancer Res 2011 1.62
3 Antibody protection against botulinum neurotoxin intoxication in mice. Infect Immun 2009 1.43
4 Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. PLoS One 2009 1.35
5 Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. J Immunol 2007 1.32
6 Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. PLoS One 2010 1.28
7 Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. J Clin Invest 2011 1.25
8 A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region. J Mol Biol 2010 1.10
9 Isolation of scFvs to in vitro produced extracellular domains of EGFR family members. Cancer Biother Radiopharm 2005 1.06
10 Using phage display to select antibodies recognizing post-translational modifications independently of sequence context. Mol Cell Proteomics 2006 1.00
11 Yeast mating for combinatorial Fab library generation and surface display. FEBS Lett 2004 0.99
12 Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy. J Biol Chem 2007 0.98
13 Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies. Mol Cancer Ther 2012 0.92
14 Tumor detection by imaging proteolytic activity. Cancer Res 2010 0.92
15 Antibodies in proteomics II: screening, high-throughput characterization and downstream applications. Trends Biotechnol 2003 0.90
16 Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis C virus. J Biol Chem 2011 0.88
17 Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant antibodies. Anal Chim Acta 2006 0.88
18 Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies. Biosens Bioelectron 2009 0.87
19 Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E. Biochem J 2013 0.86
20 Antibodies in proteomics I: generating antibodies. Trends Biotechnol 2003 0.86
21 Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. BMC Biochem 2011 0.85
22 Renewable surface fluorescence sandwich immunoassay biosensor for rapid sensitive botulinum toxin detection in an automated fluidic format. Analyst 2009 0.84
23 Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays. Anal Biochem 2012 0.82
24 Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity. Anal Chem 2009 0.81
25 RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin. Talanta 2013 0.80
26 Development of human single-chain antibodies against SARS-associated coronavirus. Intervirology 2008 0.79
27 Development of an ELISA microarray assay for the sensitive and simultaneous detection of ten biodefense toxins. Analyst 2014 0.78